TherapeuticsMD, Inc. 4
4 · TherapeuticsMD, Inc. · Filed Nov 24, 2014
Insider Transaction Report
Form 4
Cartwright Daniel A
CFO, VP Finance, Treasurer
Transactions
- Sale
Common Stock
2014-11-21$3.93/sh−20,000$78,686→ 0 total - Sale
Common Stock
2014-11-20$3.88/sh−20,000$77,598→ 20,000 total - Exercise/Conversion
Common Stock
2014-11-20$0.38/sh+40,000$15,200→ 40,000 total - Exercise/Conversion
Non-qualified stock
2014-11-20−40,000→ 260,000 totalExercise: $0.38From: 2012-10-21Exp: 2021-10-21→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]The shares were sold pursuant to a 10b5-1 Sales Plan dated September 8, 2014.
- [F2]The options were exercised and the price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $3.82 to $3.93, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $3.85 to $4.00, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.